sb 203580 has been researched along with medroxyprogesterone acetate in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 5,123 | 1,115 | 1,099 |
Protein | Taxonomy | sb 203580 (IC50) | medroxyprogesterone acetate (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.924 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
Progesterone receptor | Homo sapiens (human) | 2.5081 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
Androgen receptor | Homo sapiens (human) | 0.0061 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
Estrogen receptor beta | Homo sapiens (human) | 0.924 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arici, A; Buchwalder, LF; Kayisli, UA; Kizilay, G; Lockwood, CJ; Murk, W; Oner, C; Schatz, F | 1 |
1 other study(ies) available for sb 203580 and medroxyprogesterone acetate
Article | Year |
---|---|
Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery.
Topics: Blotting, Western; Chorioamnionitis; Decidua; Enzyme-Linked Immunosorbent Assay; Female; Humans; Imidazoles; Immunohistochemistry; Interleukin-1beta; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Protein Kinase Inhibitors; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2008 |